Nichi-Glucan helps Covid-19 patients in clinical study
15/8/2021
Covid-19: Cytokine storm and Coagulopathy biomarke…
News
Asia, Singapore edition has reported
21/7/2021
Article of clinical pilot study of Nichi Glucan in Autism Spectrum Disorder is
Survey on public healthcare systems in TN state, India published
19/7/2021
A joint Japan- India survey on TN state public hea…
Article on NICHI GLUCAN, published in a journal of Neurology specialty
24/6/2021
Nichi Glucan’s potentials has been published…
BEES-HAUS technique proven successful in pre-clinical study
10/6/2021
BEES HAUS is a new regenerative medicine solution for male urethral stricture
Article on NICHIGLUCAN was published in Agriculture and Food magazine from Italy
30/4/2021
“NICHIGLUCAN- potentials and clinical studies published in “Agro FOOD Industry- Hi tech”, an Italian magazine.
13 years of basic research data of GN Corporation published in paper
6/4/2021
GN Corporation published 13 years of basic research data in The Tokai Journal of Experimental and Clinical Medicine.
Press Release
Tackling long COVID-19, with safety proven Japanese Beta Glucans; The first clinical report in the world
8/10/2021
Paper on potential of beta glucan products is pubrished
Path-breaking feat of reversing in-vitro aging of human chondrocytes; published in Nature Journal
10/7/2021
The paper is published in Scientific Reports, Nature Journal
New Advances in Regenerative Treatments for Cartilage Injuries Published in THE KNEE
11/3/2021
GNC succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D